beta
/Radioluminescent Nanoparticles For Radiation-triggered Controlled Release Drugs
Abstract

The present disclosure relates to novel radiation-triggered controlled release drug compositions, and methods to make and use the radiation-triggered controlled release drug compositions. The radiation-triggered controlled drug release nanoparticle formulations may be used to achieve maximum bioavailability and minimum adverse effects of the chemo drugs in chemo radio combination therapy treatment of locally advanced solid tumors.

Full Text

What is claimed is:

The present disclosure relates to novel radiation-triggered controlled release drug compositions, and methods to make and use the radiation-triggered controlled release drug compositions. The radiation-triggered controlled drug release nanoparticle formulations may be used to achieve maximum bioavailability and minimum adverse effects of the chemo drugs in chemo radio combination therapy treatment of locally advanced solid tumors.
Timeline
Filed
02/25/2026
Published
07/02/2026
Granted
Not Available
IPC Codes(6)
A61K 41/00:Medicinal preparations obtained by treating materials with wave energy or particle radiation
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 9/48:Preparations in capsules, e.g. of gelatin, of chocolate